The macrolide antibiotics: A pharmacokinetic and pharmacodynamic overview : Novel Immunomodulatory Effects of Macrolides in Inflammatory Lung DiseaseJAIN, R; DANZIGER, L. H.Current pharmaceutical design. 2004, Vol 10, Num 25, pp 3045-3053, issn 1381-6128, 9 p.Article

Bacterial resistance to β-lactam antibioticsDANZIGER, L. H; PENDLAND, S. L.American journal of health-system pharmacy. 1995, Vol 52, Num 6, pp S3-S8, issn 1079-2082, SUP2Article

Ampicillin-sulbactam and ticarcillin-clavulanic acid : a comparison of their in vitro activity and review of their clinical efficacyITOKAZU, G. S; DANZIGER, L. H.Pharmacotherapy. 1991, Vol 11, Num 5, pp 382-414, issn 0277-0008Article

Dis pyramid-induced urinary retention. Report of nine cases and review of the literatureDANZIGER, L. H; HORN, J. R.Archives of internal medicine (1960). 1983, Vol 143, Num 9, pp 1683-1686, issn 0003-9926Article

Continuous infusion of loop diuretics in the critically ill : a review of the literatureMARTIN, S. J; DANZIGER, L. H.Critical care medicine. 1994, Vol 22, Num 8, pp 1323-1329, issn 0090-3493Article

Neglected pathogens : bacterial infections in persons with human immunodeficiency virus infection : a review of the literature : first of two partsFISH, D. N; DANZIGER, L. H.Pharmacotherapy. 1993, Vol 13, Num 5, pp 415-439, issn 0277-0008Article

Selective decontamination of the digestive tract as an infection-control measure in intensive care unit patientsOCCHIPINTI, D. J; ITOKAZU, G; DANZIGER, L. H et al.Pharmacotherapy. 1992, Vol 12, Num 6, pp 50S-63S, issn 0277-0008, 2Article

Neglected pathogens : bacterial infections in persons with human immunodeficiency virus infection : a review of the literature. IIFISH, D. N; DANZIGER, L. H.Pharmacotherapy. 1993, Vol 13, Num 6, pp 543-563, issn 0277-0008Conference Paper

Fetal salvage with maternal total parenteral nutrition: the pregnant mother as her own controlSTELLATO, T. A; DANZIGER, L. H; BURKONS, D et al.JPEN. Journal of parenteral and enteral nutrition. 1988, Vol 12, Num 4, pp 412-413, issn 0148-6071, 2 p.Article

Phenobarbital pharmacokinetics in obesity : a case reportWILKES, L; DANZIGER, L. H; RODVOLD, K. A et al.Clinical pharmacokinetics. 1992, Vol 22, Num 6, pp 481-484, issn 0312-5963Article

Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infectionsMESSICK, C. R; MAMDANI, M; MCNICHOLL, I. R et al.Pharmacotherapy. 1998, Vol 18, Num 1, pp 175-183, issn 0277-0008Article

In vitro activities of metronidazole and its hydroxy metabolite against bacteroides sppPENDLAND, S. L; PISCITELLI, S. C; SCHRECKENBERGER, P. C et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 9, pp 2106-2110, issn 0066-4804Article

Moxalactam vs tobramycin-clindamycin: a randomized trial in secondary peritonitisSTELLATO, T. A; DANZIGER, L. H; HAU, T et al.HAU, T et al.Archives of surgery (Chicago, IL. 1960). 1988, Vol 123, Num 6, pp 714-717, issn 0004-0010Article

In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pyloriPENDLAND, S. L; PRAUSE, J. L; NEUHAUSER, M. M et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 9, pp 2518-2520, issn 0066-4804Article

In-vitro synergy of paromomycin with metronidazole alone or metronidazole plus hydroxymetronidazole against Helicobacter pyloriMEYER, J. M; SEONYOUNG RYU; PENDLAND, S. L et al.Journal of antimicrobial chemotherapy (Print). 1999, Vol 43, Num 3, pp 403-406, issn 0305-7453Article

Eikenella corrodens as an intra-abdominal pathogenDANZIGER, L. H; SCHOONOVER, L. L; KALE, P et al.The American surgeon. 1994, Vol 60, Num 4, pp 296-299, issn 0003-1348Article

Therapeutic monitoring and pharmacist intervention in a Hansen's disease clinicPISCITELLI, S. C; OCCHIPINTI, D. J; DANZIGER, L. H et al.The Annals of pharmacotherapy. 1993, Vol 27, Num 12, pp 1526-1531, issn 1060-0280Article

Surveillance of treated and untreated funguria in a university hospitalGUBBINS, P. O; OCCHIPINTI, D. J; DANZIGER, L. H et al.Pharmacotherapy. 1994, Vol 14, Num 4, pp 463-470, issn 0277-0008Conference Paper

Clarithromycin and azithromycin : new macrolide antibioticsPISCITELLI, S. C; DANZIGER, L. H; RODVOLD, K. A et al.Clinical pharmacy. 1992, Vol 11, Num 2, pp 137-152, issn 0278-2677Article

Treatment of cryptosporidial diarrhea in an AIDS patient with paromomycinDANZIGER, L. H; KANYOK, T. P; NOVAK, R. M et al.The Annals of pharmacotherapy. 1993, Vol 27, Num 12, pp 1460-1462, issn 1060-0280Article

Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and Monte Carlo simulationDRUSANO, G. L; PRESTON, S. L; GOTFRIED, M. H et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 2, pp 586-589, issn 0066-4804Article

Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolonesPENDLAND, S. L; MARTIN, S. J; CHEN, C et al.Journal of clinical microbiology (Print). 1997, Vol 35, Num 11, pp 3004-3006, issn 0095-1137Article

Development of resistance during antimicrobial therapy : a review of antibiotic classes and patient characteristics in 173 studiesFISH, D. N; PISCITELLI, S. C; DANZIGER, L. H et al.Pharmacotherapy. 1995, Vol 15, Num 3, pp 279-291, issn 0277-0008Conference Paper

Activity of aminosidine (paromomycin) for Mycobacterium tuberculosis and Mycobacterium aviumKANYOK, T. P; VENKATA REDDY, M; JAGANNATH CHINNASWAMY et al.Journal of antimicrobial chemotherapy (Print). 1994, Vol 33, Num 2, pp 323-327, issn 0305-7453Article

In vivo activity of paromomycin against susceptible and multidrug-resistant Mycobacterium tuberculosis and M. avium complex strainsKANYOK, T. P; REDDY, M. V; CHINNASWAMY, J et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 2, pp 170-173, issn 0066-4804Article